| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |